Flynn James E 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 0 0.000% |
-3,959,741![]() (Position Closed) |
Filing |
2021-02-12 12:30 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 3,959,741 9.960% |
1,681,588![]() (+73.81%) |
Filing |
2020-08-10 2:52 pm Purchase |
2020-08-07 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 2,278,153 5.740% |
2,278,153![]() (New Position) |
Filing |